Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2022, Vol. 08 ›› Issue (02): 173-179. doi: 10.3877/cma.j.issn.2096-1537.2022.02.014

• Review • Previous Articles     Next Articles

Advances in photobiomodulation as adjunctive therapy in severe pulmonary infections

Qingqing Guo1, Jiandong Lin1,()   

  1. 1. Department of Critical Care Medicine, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
  • Received:2022-01-16 Online:2022-07-04 Published:2022-07-05
  • Contact: Jiandong Lin

Abstract:

Pulmonary infection is one of the commonest infectious diseases in clinical practice. Its incidence and mortality rates increase year by year. Severe pneumonia, especially COVID-19, places a significant burden on societies and families. There is, therefore, an urgent need to develop more effective antimicrobial and anti-inflammatory strategies to control severe pulmonary infections. PBM, with intracellular photochemical reactions affecting cellular metabolic pathways and gene expression patterns, is a novel therapeutic tool in medicine. It has antibacterial and bactericidal effects, eliminate inflammation, regulate immunity, and promote blood circulation and tissue repair. This review focuses on the cellular and molecular mechanisms of PBM to explore the feasibility of PBM as adjuvant therapy for pulmonary infection and find new treatment strategies for patients with severe pneumonia and improve their prognosis.

Key words: Photobiomodulation, Severe pneumonia, Low-level laser therapy

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd